Adoption of medications as first-line treatments of lyme disease and research on antibiotic therapies creating lucrative avenues; growing awareness of incidence and burden of disease in canines expanding avenues in lyme disease treatment market
Early diagnosis using advanced assays enriching prospects; Prevalence of lyme disease in North America, attributed to rising tick-borne diseases, presents ample opportunities
WILMINGTON, Del., Sept. 29, 2022 /PRNewswire/ -- Rise in prevalence of lyme disease in humans as well as animals and awareness of the long-term health impacts for those affected are fueling the growth of lyme disease treatment market. Rise in adoption of medications notably generic medicines and acceptance of antibiotic therapies have propelled sales of lyme disease treatment market. The lyme disease treatment market size is forecast to reach US$ 3 Bn by 2031.
Growing spending on clinical studies particularly placebo-controlled clinical trials has expanded the clinical understanding of the disease, thereby enabling researchers to develop more effective management strategies, thus catalyzing lyme disease treatment market growth. Of note, growing number of randomized placebo–controlled clinical trials in developed regions such as Europe and North America will pave the way for treatments that can reduce the burden of new tick-borne disease cases.
Get Exclusive PDF Sample Copy of Lyme Disease Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=76335
An in-depth TMR study on the lyme disease treatment market observed that introduction of many advanced diagnostics with high sensitivity and specificity have enriched the value chain of players. Focus of diagnostic companies on diagnosing the most prevalent tick-borne pathogens in multiple ways will open up new revenue streams. They are assisting clinicians in early diagnosis of the lyme disease.
Key Findings of Lyme Disease Treatment Market Study
Widespread Adoption of Medications Particularly Oral Propelling Revenue Generation: Rising demand for medications for lyme disease treatment has steered substantial revenue streams. Of note, oral medications present a large lucrative avenue, and they are preferred for blocking joint pain. Companies have benefited from the commercialization of novel diagnostic assays that aim for accurate and timely diagnosis.
Growing Awareness of lyme Disease in Animals Expanding Prospects: Incidence of lyme disease in small animals has grown significantly. Particularly in dogs, the need for diagnosis and treatment is high. Stridently, rise in pet ownership will expand the canvas for players in lyme disease treatment market. Nation health agencies are geared toward exploring novel approaches for the diagnosis and treatment of the lyme disease. Occurrence of post-treatment lyme disease syndrome (PTLDS) is a concerning issue for the healthcare community, in large part due to glaring rates of initial delayed or misdiagnosis. They are raising awareness about vector borne diseases in endemic areas.
Ask for References – https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=76335
Lyme Disease Treatment Market: Key Drivers
Increase in tick-borne diseases including those caused by emerging vector-borne pathogens is a key driver of lyme disease treatment market. Ongoing studies on expanding clinical understanding of lyme disease will expand the horizon for more effective diagnosis and treatment of the disease.
Growing initiatives by governments for raising the awareness of veterinary care and burden of the lyme disease on small animals are creating promising growth avenues for firms in lyme disease treatment market.
Lyme Disease Treatment Market: Regional Dynamics
North America has witnessed enormous revenue prospects and is anticipated to remain lucrative throughout the forecast period. High prevalence of tick-borne or vector-borne diseases has spurred the need for novel treatments for lyme disease. Growing investment by medical research agencies in the region is spurring the revenue generation. Commercialization of advanced diagnostic methods and medications for the management of lyme disease is reinforcing the pace of revenue generation in the regional market in recent years.
Make an Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=76335
Lyme Disease Treatment Market: Key Players
Some of the key players in lyme disease treatment market include Amneal Pharmaceuticals LLC, Orion Corporation, Perrigo Company plc., Perrigo Company plc., Lupin Pharmaceuticals, Inc. Almirall, LLC, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer, Inc., GlaxoSmithKline plc.
Companies are increasingly focused on harnessing retail pharmacy distributions to consolidate their positions in the near future.
Lyme Disease Treatment Market Segmentation
Type of Bacteria
Route of Administration
Middle East & Africa
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:
Dyspareunia Treatment Market: The global dyspareunia treatment market is anticipated to reach more than US$ 1.02 Bn by the end of 2031 and to grow at a CAGR of 4.1% from 2022 to 2031.
Nanoparticle Contract Manufacturing Market: The global nanoparticle contract manufacturing market is anticipated to reach more than US$ 176.5 Bn by the end of 2031.
Anticoagulant Reversal Drugs Market: The global anticoagulant reversal drugs market is anticipated to reach more than US$ 2.3 Bn by the end of 2031.
Macular Degeneration Treatment Market: The global macular degeneration treatment market is anticipated to reach more than US$ 21.1 Bn by the end of 2031.
PET Radiotracer Market: The global PET radiotracer market is anticipated to reach more than US$ 3.2 Bn by the end of 2031 and to grow at a CAGR of 8.5% from 2022 to 2031.
Gemcitabine HCL Market: The global gemcitabine HCl market is anticipated to reach more than US$ 1.3 Bn by 2031 and to grow at a CAGR of 7.8% from 2022 to 2031.
Topical Antibiotics Market: The global topical antibiotics market is anticipated to attain a market value of US$ 8.3 Bn by the end of 2030.
Red Biotechnology Market: The global red biotechnology market is anticipated to reach more than US$ 609.6 Bn by the end of 2031 at a CAGR of 5.6% from 2022 to 2031.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
USA – Canada Toll Free: 866-552-3453
SOURCE Transparency Market Research